Resveratrol counters systemic lupus erythematosus-associated atherogenicity by normalizing cholesterol efflux

This study presents evidence for a beneficial role of resveratrol in atherosclerosis in the specific setting of SLE. Therefore, resveratrol may merit investigation as an additional resource available to reduce lipid deposition and atherosclerosis in humans, especially in such vulnerable populations as lupus patients.

Source: Experimental Biology and Medicine - July 28, 2016 Category: Research Authors: Voloshyna, I., Teboul, I., Littlefield, M. J., Siegart, N. M., Turi, G. K., Fazzari, M. J., Carsons, S. E., DeLeon, J., Reiss, A. B. Tags: Translational Research Source Type: research